MYCN and neuroblastoma: Four human neuroblastoma cell lines including MYCN-amplified, BE(2)-C, CHP-212, and LAN-1, as well as the non-MYCN amplified cell line, SK-N-AS, were treated with methotrexate or pralatrexate.